trending Market Intelligence /marketintelligence/en/news-insights/trending/gnvjao3hmrug_1kpczthja2 content esgSubNav
In This List

Advaxis names CFO

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Advaxis names CFO

Advaxis Inc. appointed Molly Henderson executive vice president and CFO, effective June 6.

Before Advaxis, Henderson worked at Cedar Cliff LLC, where she served as a financial and business consultant to entrepreneurial companies.

Princeton, N.J.-based Advaxis is a clinical stage biotechnology company, which focuses on the discovery, development and commercialization of Listeria monocytogenes technology-based immunotherapies in the U.S.